| RAPP Rapport Therapeutics, Inc. | PAUL STEVEN M Director | Open-market buy | 35,714 | $27.28 | $974.3K | 2026-10-22 |
| RAPP Rapport Therapeutics, Inc. | MARAGANORE JOHN Director | Open-market buy | 8,239 | $26.38 | $217.3K | 2026-10-22 |
| RAPP Rapport Therapeutics, Inc. | Young Wendy B. Director | Open-market buy | 3,789 | $26.39 | $100K | 2026-10-22 |
| RAPP Rapport Therapeutics, Inc. | Silva Paul M Director | Open-market buy | 3,680 | $27.07 | $99.6K | 2026-10-22 |
| XFLT XAI Floating Rate & Alternative Income Trust | Spence John Yogi Other | Open-market buy | 2,000 | $17.07 | $34.1K | 2026-10-21 |
| RAPP Rapport Therapeutics, Inc. | MARAGANORE JOHN Director | Open-market buy | 1,172 | $26.92 | $31.5K | 2026-10-22 |
| VKI Invesco Advantage Municipal Income Trust II | BANK OF AMERICA CORP /DE/ 10% owner | Open-market buy | 105 | $8.03 | $843.2 | 2026-10-20 |
| NMS Nuveen Minnesota Quality Municipal Income Fund | BANK OF AMERICA CORP /DE/ 10% owner | Open-market buy | 82 | $10.25 | $840.5 | 2026-10-20 |
| NMS Nuveen Minnesota Quality Municipal Income Fund | BANK OF AMERICA CORP /DE/ 10% owner | Open-market buy | 18 | $10.21 | $183.9 | 2026-10-20 |
| SRZN Surrozen, Inc./DE | COLUMN GROUP III GP, LP 10% owner | Option exercise | 548,653 | $11.60 | $6.4M | 2026-10-20 |
| SRZN Surrozen, Inc./DE | Kutzkey Tim Director | Option exercise | 548,653 | $11.60 | $6.4M | 2026-10-20 |
| SRZN Surrozen, Inc./DE | COLUMN GROUP III GP, LP 10% owner | Option exercise | 517,241 | $11.60 | $6M | 2026-10-20 |
| SRZN Surrozen, Inc./DE | Kutzkey Tim Director | Option exercise | 517,241 | $11.60 | $6M | 2026-10-20 |
| SRZN Surrozen, Inc./DE | COLUMN GROUP III GP, LP 10% owner | Option exercise | 485,830 | $11.60 | $5.6M | 2026-10-20 |
| SRZN Surrozen, Inc./DE | Kutzkey Tim Director | Option exercise | 485,830 | $11.60 | $5.6M | 2026-10-20 |
| ALLY Ally Financial Inc. | Timmerman Douglas R. President, DFS | Tax withholding | 98,329 | $37.97 | $3.7M | 2026-10-20 |
| BB BLACKBERRY Ltd | GIAMATTEO JOHN JOSEPH CEO & President, Secure Comm. | Open-market sale | 151,000 | $9.40 | $1.4M | 2026-10-21 |
| ALLY Ally Financial Inc. | Patterson Kathleen L. Chief HR & Corp Citizenship | Tax withholding | 31,047 | $37.97 | $1.2M | 2026-10-20 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise | 9,500 | $117.76 | $1.1M | 2026-10-21 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 1,702 | $557.25 | $948.4K | 2026-10-21 |
| BB BLACKBERRY Ltd | GIAMATTEO JOHN JOSEPH CEO & President, Secure Comm. | Open-market sale | 99,000 | $8.74 | $865.3K | 2026-10-22 |
| ALLY Ally Financial Inc. | Hutchinson Russell E. Chief Financial Officer | Tax withholding | 21,074 | $37.97 | $800.2K | 2026-10-20 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 1,253 | $563.43 | $706K | 2026-10-21 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 1,137 | $558.32 | $634.8K | 2026-10-21 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 960 | $562.54 | $540K | 2026-10-21 |
| ALLY Ally Financial Inc. | Patterson Kathleen L. Chief HR & Corp Citizenship | Open-market sale | 12,831 | $38.65 | $495.9K | 2026-10-21 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 820 | $560.50 | $459.6K | 2026-10-21 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 768 | $564.63 | $433.6K | 2026-10-21 |
| SBET Sharplink, Inc. | Sheffield Matthew A Chief Investment Officer | Tax withholding | 53,211 | $7.87 | $418.8K | 2026-10-20 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 743 | $559.25 | $415.5K | 2026-10-21 |
| ALLY Ally Financial Inc. | Hall William Cadik Jr. President - Corporate Finance | Tax withholding | 10,614 | $37.97 | $403K | 2026-10-20 |
| CHYM Chime Financial, Inc. | King Ryan A Co-Founder | Open-market sale | 11,318 | $31.03 | $351.2K | 2026-10-20 |
| ALLY Ally Financial Inc. | Richard Stephanie N Chief Risk Officer | Tax withholding | 9,032 | $37.97 | $342.9K | 2026-10-20 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 567 | $556.41 | $315.5K | 2026-10-21 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 550 | $555.19 | $305.4K | 2026-10-21 |
| UTHR UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A Chairperson & CEO | Open-market sale | 480 | $565.36 | $271.4K | 2026-10-21 |
| HERZ Herzfeld Credit Income Fund, Inc | HERZFELD THOMAS J Other | Disposition to issuer | 14,147 | $18.20 | $257.5K | 2026-10-20 |
| PLXS PLEXUS CORP | Kelsey Todd P. President & CEO | Open-market sale | 779 | $238.47 | $185.8K | 2026-10-21 |
| PLXS PLEXUS CORP | Kelsey Todd P. President & CEO | Open-market sale | 721 | $239.92 | $173K | 2026-10-21 |
| BKE BUCKLE INC | WERTH SCOTT A SVP Stores | Open-market sale | 2,500 | $46.75 | $116.9K | 2026-10-22 |